Tibet Cheezheng Tibetan Medicine Co Ltd Cash Flow Reinvestment Rate
Tibet Cheezheng Tibetan Medicine Co Ltd cash flow reinvestment rate. Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Cash Flow Reinvestment Rate of 1.20x as of September 2025, reinvesting CN¥41.69 Million (capex CN¥41.69 Million ) from operating cash flow of CN¥34.69 Million. See financial flexibility index of Tibet Cheezheng Tibetan Medicine Co Ltd to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Cash flow reinvestment rate of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025. Historical reinvestment intensity for Tibet Cheezheng Tibetan Medicine Co Ltd across 19 annual periods. Explore Tibet Cheezheng Tibetan Medicine Co Ltd (002287) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Tibet Cheezheng Tibetan Medicine Co Ltd Cash Flow Reinvestment Rate by Year (2006–2025)
Tibet Cheezheng Tibetan Medicine Co Ltd cash flow reinvestment rate by year from 2006 to 2025. Year-by-year capital reinvestment analysis for Tibet Cheezheng Tibetan Medicine Co Ltd. For the full cash flow conversion analysis, see Tibet Cheezheng Tibetan Medicine Co Ltd cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | CN¥326.76 Million | CN¥729.70 Million | CN¥153.08 Million | ▼ -60.5% |
| 2024 | 1.13x | CN¥518.02 Million | CN¥456.75 Million | CN¥255.44 Million | ▲ +153.2% |
| 2023 | 0.45x | CN¥310.63 Million | CN¥693.41 Million | CN¥234.81 Million | ▼ -64.9% |
| 2022 | 1.28x | CN¥364.96 Million | CN¥285.69 Million | CN¥272.40 Million | ▼ -37.3% |
| 2021 | 2.04x | CN¥2.11 Billion | CN¥1.03 Billion | CN¥125.57 Million | ▼ -20.0% |
| 2020 | 2.55x | CN¥608.22 Million | CN¥238.65 Million | CN¥338.97 Million | ▲ +123.8% |
| 2019 | 1.14x | CN¥462.27 Million | CN¥405.95 Million | CN¥52.27 Million | ▲ +327.3% |
| 2018 | 0.27x | CN¥133.09 Million | CN¥499.40 Million | CN¥128.94 Million | ▼ -78.7% |
| 2017 | 1.25x | CN¥287.13 Million | CN¥229.83 Million | CN¥66.13 Million | ▲ +72.9% |
| 2016 | 0.72x | CN¥281.15 Million | CN¥389.20 Million | CN¥179.87 Million | ▼ -6.1% |
| 2015 | 0.77x | CN¥198.24 Million | CN¥257.81 Million | CN¥64.90 Million | ▲ +193.5% |
| 2014 | 0.26x | CN¥81.48 Million | CN¥310.95 Million | CN¥81.48 Million | ▼ -30.1% |
| 2013 | 0.37x | CN¥74.38 Million | CN¥198.48 Million | CN¥74.38 Million | ▲ +3.1% |
| 2012 | 0.36x | CN¥61.65 Million | CN¥169.67 Million | CN¥61.65 Million | ▼ -38.6% |
| 2010 | 0.59x | CN¥57.32 Million | CN¥96.91 Million | CN¥57.32 Million | ▲ +531.7% |
| 2009 | 0.09x | CN¥16.44 Million | CN¥175.58 Million | CN¥16.44 Million | ▼ -74.1% |
| 2008 | 0.36x | CN¥23.79 Million | CN¥65.93 Million | CN¥23.79 Million | ▲ +8.2% |
| 2007 | 0.33x | CN¥30.49 Million | CN¥91.43 Million | CN¥30.49 Million | ▼ -7.7% |
| 2006 | 0.36x | CN¥13.91 Million | CN¥38.50 Million | CN¥13.91 Million | — |